bullish
Ocumension Theraputics Placement - IPO Was Hot, Deal Should Be Supported Despite Lock-Up Expiry
263 Views12 Jan 2021 18:52
Ocumension Therapeutics (1477 HK) aims to raise around US$103m to commercialize new products, fund clinical trials and develop new facilities.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
- Ocumension Theraputics Placement - IPO Was Hot, Deal Should Be Supported Despite Lock-Up Expiry12 Jan 2021
- Ocumension (欧康维视) IPO Trading: Share Could Double Thanks to Record Demand09 Jul 2020
- Ocumension (欧康维视) IPO: Hot Deal, Small Float29 Jun 2020
x